Migration of a Percutaneous Endoscopic Gastrojejunostomy Tube into the Colon with Small Intestinal Telescoping
Continuous duodenal levodopa/carbidopa intestinal gel delivery by a gastrostomy infusion system improves control of Parkinson’s disease. The overall complication rates of percutaneous endoscopic gastrojejunostomy were reported to be 41% and 59% for immediate and delayed adverse events, respectively....
Main Authors: | Shinya Taki, Takao Maekita, Mayumi Sakata, Kazuhiro Fukatsu, Yoshimasa Maeda, Mikitaka Iguchi, Hidefumi Ito, Masayuki Kitano |
---|---|
Format: | Article |
Language: | English |
Published: |
Hoon Jai Chun
2019-11-01
|
Series: | Clinical Endoscopy |
Subjects: | |
Online Access: | http://www.e-ce.org/upload/pdf/ce-2019-016.pdf |
Similar Items
-
Complications of percutaneous endoscopic gastrostomy-jejunostomy for levodopa/carbidopa infusion in advanced Parkinson's disease
by: Ana Olivares, et al.
Published: (2012-03-01) -
The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study
by: Kanefumi Yamashita, et al.
Published: (2021-06-01) -
Dopaminergic agents: back to the basics – a small review
by: Neha Sharma, et al.
Published: (2017-12-01) -
Percutaneous radiologic gastrostomy in patients with failed percutaneous endoscopic gastrostomy
by: Tang-fei Lee, et al.
Published: (2017-10-01) -
How replace the gastrostomy tube in children with extremely compromised general conditions
by: Carmine Noviello, et al.
Published: (2019-01-01)